Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 30, 2023 -- About one in five immunosuppressed individuals have no detectable immunoglobulin (Ig)G anti-spike antibodies, even after three or more COVID-19 vaccines, according to a study published in the August issue of The Lancet Rheumatology.
Fiona A. Pearce, Ph.D., from the University of Nottingham in the United Kingdom, and colleagues examined the association between seropositivity to the SARS-CoV-2 spike protein with demographic, disease, and treatment-related characteristics after at least three COVID-19 vaccines in participants with rare autoimmune rheumatic diseases, participants with lymphoid malignancies, and recipients of solid organ transplants.
A total of 28,411 individuals were recruited to the study; 81.1 percent provided serological data. Of those patients, 28.6, 61.8, and 9.6 percent had received three, four, and five or more vaccine doses, respectively. The researchers found that IgG anti-spike antibodies were undetectable in 23.3, 14.1, and 20.7 percent of patients with solid organ transplants, those with rare autoimmune rheumatic diseases, and patients with lymphoid malignancies, respectively. Seropositivity was associated with younger age, a higher number of vaccine doses, and previous COVID-19 in all groups. The likelihood of seropositivity was reduced with immunosuppressive medication; the odds of seropositivity were lowest for solid organ transplant recipients receiving a combination of an antiproliferative agent, a calcineurin inhibitor, and steroids and those with rare autoimmune rheumatic diseases or lymphoid malignancies treated with anti-CD20 therapies.
"Our data also support the continued uptake of boosters in patients who are immunosuppressed, with seroconversion rates increasing with sequential vaccine doses," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
Cannabis Use Tied to Risk of COVID-19 Hospitalizations, ICU Admissions
TUESDAY, June 25, 2024 -- Current cannabis use may be an independent risk factor for COVID-19–related complications, according to a study published online June 21...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.